Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness and tolerability of topiramate compared to placebo in patients with binge eating disorder receiving Cognitive Behavior Therapy (CBT)


Clinical Trial Description

This was a 21-week multicenter, double-blind, parallel-group, randomized controlled trial comparing the efficacy and tolerability of an add-on treatment with 200mg of topiramate versus placebo in obese patients with BED receiving group CBT. The aim of this trial is to investigate the efficacy and tolerability of adjunctive topiramate to CBT in obese patients with BED through improvement in binge eating, related psychopathology, and weight loss. The study hypothesis is that the patients using topiramate + CBT will loose more weight than patients using placebo + CBT.Tolerability will be investigated through reported adverse events and dropouts, with reasons for leaving the study being analyzed. The randomized patients will receive capsules of topiramate (25 mg, 50 mg) or placebo correspondent daily for 21 weeks ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00307619
Study type Interventional
Source Janssen-Cilag Farmaceutica Ltda.
Contact
Status Completed
Phase Phase 3
Start date November 2003
Completion date April 2005

See also
  Status Clinical Trial Phase
Recruiting NCT04038190 - A Behavioral Activation Intervention Administered in a College Freshman Orientation Course Phase 2
Terminated NCT04278755 - Binge Eating & Birth Control Phase 2
Completed NCT00537810 - Treatment of Binge Eating in Obese Patients in Primary Care Phase 4
Recruiting NCT05509257 - Naltrexone Neuroimaging in Teens With Eating Disorders Early Phase 1
Completed NCT03687658 - Applying Novel Technologies and Methods to Self-Regulation: Behavior Change Tools for Smoking and Binge Eating N/A
Recruiting NCT05937243 - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating N/A
Completed NCT00607789 - Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression Phase 4
Completed NCT04117542 - Working Memory in Overweight Children With and Without Loss of Control Eating
Recruiting NCT04211818 - Analysis of the Glycemic Profile of People Suffering From Compulsive Eating Disorders Aiming to Offer an Innovative Nutritional Approach (GLUCOPULSE) N/A
Completed NCT03429114 - Emotion Regulation in Binge Eating and Purging Among Adolescents
Completed NCT05041660 - Using Virtual Reality and Sensor Technology to Enhance Outcomes From Treatment for Binge Eating N/A
Completed NCT03007459 - The Health of Competitive Fitness Athletes
Completed NCT02180984 - The Effects of Repetitive Transcranial Magnetic Stimulation in Obese People With BED N/A
Completed NCT00829283 - Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care N/A
Active, not recruiting NCT04127214 - The ITA Model of Integrated Treatment of Eating Disorders
Not yet recruiting NCT06129461 - A Single Session Self-guided Acceptance-based Digital Intervention Targeting Food Cravings in Pregnancy N/A
Recruiting NCT05177705 - The Intersection Between Loss of Control Eating and Obesity: The Role of Restriction and Food Reinforcement Early Phase 1
Recruiting NCT02716831 - Improving Treatments for Bulimia Nervosa: Innovation in Psychological Interventions for Regulating Eating N/A
Completed NCT03850288 - Inhibitory Control and Eating Disorders
Completed NCT00680979 - Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity Phase 2